Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.
about
Evaluation of ERG responsive proteome in prostate cancerAutomated analysis of immunohistochemistry images identifies candidate location biomarkers for cancers.Quantitative network measures as biomarkers for classifying prostate cancer disease states: a systems approach to diagnostic biomarkers.Expression of ERG protein in prostate cancer: variability and biological correlates.Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer.Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.Humans and great apes share increased neocortical neuropeptide Y innervation compared to other haplorhine primates.EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancer.Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.Fibroblast growth factor receptor signaling plays a key role in transformation induced by the TMPRSS2/ERG fusion gene and decreased PTEN.
P2860
Q33822319-CF6405CE-754F-473B-B61A-D9305BC50B5FQ34793009-8978F844-8BF6-49C6-A16A-76B41F93FCE6Q35043487-C2CACCAD-48C1-4748-96DC-683B1A3B76DDQ35608000-6AE4CAB4-A77F-4686-978C-DAF7D26D3BF3Q36022437-6332CD5A-3485-4D4C-8714-8ABFB810B833Q37520447-E1C4EE23-1953-4712-9484-03EB5D9EBC5BQ37589156-A49BFECA-60E3-494A-A1EE-19B7B11BD711Q37608792-CF1D4268-C304-447B-A9E9-3AAA92240062Q38978361-9375D639-48EC-4CEF-AD40-600D1E8B5E2CQ39909790-5660DE9A-3832-4D25-AFC4-A6AD9C6987A4Q40526157-22117992-BFE0-4042-AB1E-6446099F9834Q52723926-CF81C77D-B126-48E7-BAF2-000C175AF4D8
P2860
Characterization of transcriptional changes in ERG rearrangement-positive prostate cancer identifies the regulation of metabolic sensors such as neuropeptide Y.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characterization of transcript ...... ensors such as neuropeptide Y.
@ast
Characterization of transcript ...... ensors such as neuropeptide Y.
@en
Characterization of transcript ...... ensors such as neuropeptide Y.
@nl
type
label
Characterization of transcript ...... ensors such as neuropeptide Y.
@ast
Characterization of transcript ...... ensors such as neuropeptide Y.
@en
Characterization of transcript ...... ensors such as neuropeptide Y.
@nl
prefLabel
Characterization of transcript ...... ensors such as neuropeptide Y.
@ast
Characterization of transcript ...... ensors such as neuropeptide Y.
@en
Characterization of transcript ...... ensors such as neuropeptide Y.
@nl
P2093
P2860
P1433
P1476
Characterization of transcript ...... ensors such as neuropeptide Y.
@en
P2093
Armin Graber
Christof Seifarth
Georg Schäfer
Helmut Klocker
Irmgard Verdorfer
Karin Unterberger
Karl G Kugler
Laurin A J Mueller
Maria Fälth
Petra Massoner
P2860
P304
P356
10.1371/JOURNAL.PONE.0055207
P407
P577
2013-02-04T00:00:00Z